News | May 18, 2021
Sun Pharma Advanced Research Q4FY21 loss at Rs. 56.72 Cr
The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020
The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020
The company will review FDA's response and decide on appropriate next steps soon.
The company posted net loss of Rs. 55.51 crores for the period ended December 31, 2019.
The Union Minister reviewed DST-supported SATHI-BHU facility
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
The system also introduces Imaging Scanner Interface 2 (ISI2) capability, enabling direct communication between injector and scanner to improve exam coordination and operational efficiency
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
A PRV is a tradable voucher granted by the FDA to encourage the development of new treatments for rare pediatric diseases
Subscribe To Our Newsletter & Stay Updated
